Larimar Therapeutics Inc (LRMR)
Healthcare
Biotechnology
4.00 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Larimar Therapeutics Inc (LRMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -113 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28 | -60 | -52 | -44 | -51 | -23 | -42 | -42 | -28 | -33 | -71 | -113 | |
| 0.0 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | -1.3 | |
| 1.6 | 8.6 | – | – | 0.2 | 0.1 | 2.2 | 5.5 | 6.6 | 7.6 | 8.8 | 7.0 | |
| – | – | – | – | 0.2 | 0.1 | 2.2 | 5.5 | 6.6 | – | – | – | |
| 0.8 | 6.7 | -5.5 | -0.1 | 0.6 | 0.2 | -2.0 | 2.7 | 1.7 | -2.5 | 6.2 | 47 | |
| 0.1 | 0.6 | 0.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.2 | 0.5 | 0.1 | |
| -57 | -92 | 51 | 36 | -6.9 | -0.1 | 17 | 24 | -91 | 33 | -85 | 100 | |
| – | 131 | 0.2 | 0.2 | 67 | 0.2 | 76 | – | 75 | – | – | – | |
| 108 | 129 | -2.7 | 17 | 67 | 19 | 94 | 20 | 75 | 0.0 | 162 | 65 | |
| 23 | -23 | -3.2 | 8.4 | 8.6 | -48 | 68 | 1.9 | -43 | -0.1 | 5.7 | 52 | |
| -28 | -60 | -53 | -44 | -52 | -23 | -42 | -42 | -28 | -34 | -71 | -113 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.